Abstract
Malignant mesothelioma (MM) is an aggressive tumor of the serosal surfaces with a poor prognosis. Advances in the understanding of tumor biology have led to the development of several targeted treatments, which have been evaluated in clinical trials. This article is a comprehensive review of all clinical trials evaluating the effect of targeted treatments in MM.
Original language | English |
---|---|
Journal | Cancer Chemotherapy and Pharmacology |
Volume | 68 |
Issue number | 1 |
Pages (from-to) | 1-15 |
Number of pages | 15 |
ISSN | 0344-5704 |
DOIs | |
Publication status | Published - Jul 2011 |